EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor
An EC 3.1.4.* (phosphoric diester hydrolase) inhibitor which interferes with the action of 3',5'-cyclic-nucleotide phosphodiesterase (EC 3.1.4.17).
|
|
anticoagulant
An agent that prevents blood clotting.
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
bronchodilator agent
An agent that causes an increase in the expansion of a bronchus or bronchial tubes.
vasodilator agent
A drug used to cause dilation of the blood vessels.
fibrin modulating drug
A drug that affects the function of fibrin in blood coagulation.
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
|
|
6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one
|
3,4-dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
|
ChemIDplus
|
6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone
|
ChemIDplus
|
6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril
|
ChemIDplus
|
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one
|
ChEMBL
|
3632017
|
Beilstein Registry Number
|
Beilstein
|
73963-72-1
|
CAS Registry Number
|
KEGG DRUG
|
73963-72-1
|
CAS Registry Number
|
ChemIDplus
|